MARKET WIRE NEWS
  1. Home
  2. Stock
  3. SOLTF
  4. News
SOLTF
Quote
Short
News
Articles
Message Board

Nxera Pharma Co Ltd Ord (OTCMKTS : SOLTF ) News

Nxera Pharma Co Ltd Ord (OTCMKTS: SOLTF) News Releases

SOLTF News Releases
SOLTF : OTC
GlobeNewswire
Nxera Pharma's Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia
SOLTF : OTC
GlobeNewswire
Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
SOLTF : OTC
GlobeNewswire
Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by Lilly
SOLTF : OTC
GlobeNewswire
Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
SOLTF : OTC
GlobeNewswire
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
SOLTF : OTC
SeekingAlpha
Nxera Pharma reports Q4 results
SOLTF : OTC
SeekingAlpha
Nxera Pharma Co., Ltd. (SOLTF) Q4 2025 Earnings Call Transcript
SOLTF : OTC
GlobeNewswire
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025
SOLTF : OTC
GlobeNewswire
Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals
SOLTF : OTC
GlobeNewswire
Nxera Pharma Licenses GPCR-targeted Program to Newly Founded Spin-out Company

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.